M

Mega Lifesciences PCL
SET:MEGA

Watchlist Manager
Mega Lifesciences PCL
SET:MEGA
Watchlist
Price: 32.5 THB -0.76% Market Closed
Market Cap: 28.3B THB
Have any thoughts about
Mega Lifesciences PCL?
Write Note

Balance Sheet

Balance Sheet Decomposition
Mega Lifesciences PCL

Current Assets 9.6B
Cash & Short-Term Investments 2.9B
Receivables 3.3B
Other Current Assets 3.4B
Non-Current Assets 4B
Long-Term Investments 71.8m
PP&E 2.2B
Intangibles 1.3B
Other Non-Current Assets 352.8m
Current Liabilities 3.9B
Accounts Payable 1.8B
Accrued Liabilities 873.9m
Short-Term Debt 168.7m
Other Current Liabilities 1B
Non-Current Liabilities 409.2m
Long-Term Debt 144.6m
Other Non-Current Liabilities 264.5m

Balance Sheet
Mega Lifesciences PCL

Rotate your device to view
Balance Sheet
Currency: THB
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
341
516
566
478
560
1 248
1 006
2 198
2 453
2 357
Cash
341
508
495
435
523
770
899
2 073
2 436
2 337
Cash Equivalents
0
8
71
42
37
478
108
125
17
19
Short-Term Investments
434
951
651
697
367
207
211
334
335
356
Total Receivables
2 127
2 336
2 303
2 638
2 652
2 652
2 613
2 737
3 302
3 494
Accounts Receivables
2 028
2 282
2 242
2 524
2 522
2 543
2 510
2 559
3 109
3 317
Other Receivables
99
54
61
113
130
110
103
178
193
177
Inventory
1 778
2 254
2 080
2 427
2 822
3 034
3 667
3 957
4 414
3 698
Other Current Assets
171
110
89
231
68
88
89
76
85
86
Total Current Assets
4 850
6 167
5 689
6 470
6 469
7 230
7 587
9 301
10 590
9 990
PP&E Net
980
1 031
1 164
1 183
1 426
1 771
2 214
2 103
2 151
2 225
PP&E Gross
980
1 031
1 164
1 183
1 426
1 771
0
0
0
0
Accumulated Depreciation
698
788
902
1 011
1 115
1 219
0
0
0
0
Intangible Assets
230
233
582
514
806
792
875
877
863
862
Goodwill
0
0
154
219
213
199
437
476
466
456
Long-Term Investments
507
0
5
42
496
272
229
251
258
256
Other Long-Term Assets
165
179
347
291
223
269
215
264
319
325
Other Assets
0
0
154
219
213
199
437
476
466
456
Total Assets
6 732
N/A
7 610
+13%
7 941
+4%
8 720
+10%
9 633
+10%
10 533
+9%
11 557
+10%
13 272
+15%
14 646
+10%
14 115
-4%
Liabilities
Accounts Payable
1 306
1 603
1 519
1 598
1 691
2 020
2 048
2 527
2 793
1 925
Accrued Liabilities
366
444
529
517
583
611
688
848
976
895
Short-Term Debt
354
543
654
506
956
888
499
168
229
76
Current Portion of Long-Term Debt
76
91
9
6
1
1
37
56
83
44
Other Current Liabilities
419
417
442
738
544
638
957
1 254
1 457
1 497
Total Current Liabilities
2 521
3 099
3 153
3 366
3 775
4 158
4 229
4 853
5 538
4 437
Long-Term Debt
137
84
7
0
2
1
111
132
109
132
Deferred Income Tax
3
1
1
1
1
2
1
0
0
2
Minority Interest
0
0
0
0
0
0
21
22
0
0
Other Liabilities
93
91
101
108
130
197
237
261
223
242
Total Liabilities
2 754
N/A
3 275
+19%
3 261
0%
3 475
+7%
3 908
+12%
4 358
+11%
4 599
+6%
5 269
+15%
5 870
+11%
4 813
-18%
Equity
Common Stock
433
433
433
433
433
436
436
436
436
436
Retained Earnings
1 575
1 932
2 335
2 994
3 585
4 022
4 733
5 770
6 681
7 234
Additional Paid In Capital
2 138
2 138
2 138
2 138
2 177
2 305
2 305
2 305
2 305
2 305
Other Equity
167
168
226
321
470
588
516
507
644
672
Total Equity
3 978
N/A
4 335
+9%
4 680
+8%
5 244
+12%
5 724
+9%
6 175
+8%
6 958
+13%
8 003
+15%
8 777
+10%
9 302
+6%
Total Liabilities & Equity
6 732
N/A
7 610
+13%
7 941
+4%
8 720
+10%
9 633
+10%
10 533
+9%
11 557
+10%
13 272
+15%
14 646
+10%
14 115
-4%
Shares Outstanding
Common Shares Outstanding
865
865
865
865
867
872
872
872
872
872

See Also

Discover More